Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 46, Issue 10

Issues

New sequence variants in BRCA1 and BRCA2 genes detected by high-resolution melting analysis in an elderly healthy female population in Croatia

Mirela Levacic Cvok / Maja Cretnik / Vesna Musani / Petar Ozretic / Sonja Levanat

Abstract

Background: Mutations in BRCA1 and BRCA2 genes are associated with family predisposition to breast and ovarian cancer. Novel screening methods are required for efficient and rapid detection of sequence variants in cancer patients and their family members.

Methods: The screening for variants in the breast and ovarian cancer susceptibility genes BRCA1 and BRCA2 in Croatia was performed by a high-resolution melting approach, which is based on differences in melting curves caused by variations in nucleotide sequence. This is the first screening in Croatia on elderly healthy women with no family history of cancer. BRCA1 screening was performed on 220 and BRCA2 screening on 115 samples.

Results: In a population well beyond the average age of breast/ovarian cancer onset, 21 different sequence variants in the BRCA1 gene (one novel: c.5193+49_50delTA) and 36 variants in the BRCA2 gene (7 novel: c.459A>C, c.3318C>A, c.4412_ 4414delGAA, c.4790C>A, c.6264T>C, c.9087G>A, and c.9864A>G) were detected.

Conclusions: Nine BRCA1 and seven BRCA2 known variants appeared with such high frequencies that they could be declared as harmless in this population. Eight BRCA1 high frequency variants, located further from the promoter region, appear to be strongly correlated. Three novel variants that changed the amino acid sequence of the BRCA2 protein (two missense base substitutions, c.3318C>A and c.4790C>A, and one codon deletion c.4412_4414delGAA), appearing only once, were predicted to have no potential effect on protein structure and function.

Clin Chem Lab Med 2008;46:1376–83.

Keywords: allele frequency; BRCA1; BRCA2; high-resolution melting

About the article

Corresponding author: Sonja Levanat, PhD, Division of Molecular Medicine, Rudjer Boskovic Institute, Bijenicka 54, 10000 Zagreb, Croatia Phone: +385-1-456-1110, Fax: +385-1-456-1010,


Received: 2008-02-26

Accepted: 2008-07-08

Published in Print: 2008-10-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 46, Issue 10, Pages 1376–1383, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2008.307.

Export Citation

©2008 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
MAJA SABOL, DIANA CAR, VESNA MUSANI, PETAR OZRETIC, SLAVKO ORESKOVIC, IGOR WEBER, and SONJA LEVANAT
International Journal of Oncology, 2012, Volume 41, Number 4, Page 1411
[2]
Petar Ozretić, Alessandra Bisio, Vesna Musani, Diana Trnski, Maja Sabol, Sonja Levanat, and Alberto Inga
RNA Biology, 2015, Volume 12, Number 3, Page 290
[3]
Vesna Musani, Maja Sabol, Diana Car, Petar Ozretić, Držislav Kalafatić, Ivana Maurac, Slavko Orešković, and Sonja Levanat
Gene, 2013, Volume 517, Number 1, Page 55
[4]
Ivana Maurac, Maja Sabol, Vesna Musani, Diana Car, Petar Ozretic, Drzislav Kalafatic, Slavko Oreskovic, Damir Babic, and Sonja Levanat
International Journal of Gynecological Pathology, 2012, Volume 31, Number 3, Page 264
[5]
Sonja Levanat, Vesna Musani, Mirela Levacic Cvok, Ilona Susac, Maja Sabol, Petar Ozretic, Diana Car, Domagoj Eljuga, Ljerka Eljuga, and Damir Eljuga
Gene, 2012, Volume 498, Number 2, Page 169
[6]
Panagiotis A. Vorkas, Konstantinos Christopoulos, Christos Kroupis, and Evi S. Lianidou
Clinical Biochemistry, 2010, Volume 43, Number 1-2, Page 178
[7]
Ivan Sabol, Maja Čretnik, Ita Hadžisejdić, Ali Si-Mohamed, Mihaela Matovina, Blaženka Grahovac, Sonja Levanat, and Magdalena Grce
Journal of Virological Methods, 2009, Volume 162, Number 1-2, Page 142
[8]
Neng Chen, Lisbeth Tranebjærg, Nanna Dahl Rendtorff, and Iris Schrijver
The Journal of Molecular Diagnostics, 2011, Volume 13, Number 4, Page 416
[9]
Florence Coulet, Filipe Pires, Etienne Rouleau, Cedrick Lefol, Sabrina Martin, Chrystelle Colas, Odile Cohen-Haguenauer, Irina Giurgea, Anne Fajac, Catherine Noguès, Liliane Demange, Agnès Hardouin, Rosette Lidereau, and Florent Soubrier
Genetic Testing and Molecular Biomarkers, 2010, Volume 14, Number 5, Page 677
[10]
Jesse L Montgomery, Lindsay N Sanford, and Carl T Wittwer
Expert Review of Molecular Diagnostics, 2010, Volume 10, Number 2, Page 219

Comments (0)

Please log in or register to comment.
Log in